Increasing incidence of Mycoplasma genitalium is driven by people living with HIV and PrEP users
International Journal of STD & AIDS · 2025
DOI: 10.1177/09564624251315782 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Roberto Rossotti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. Hauptthemen laut MEDLINE: Mycoplasma genitalium, HIV Infections, Mycoplasma Infections, Pre-Exposure Prophylaxis. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Mycoplasma genitalium (MG) is responsible for non-gonococcal urethritis. Our aim is to describe MG positivity rate and incidence in specific populations.
Methods
Retrospective, surveillance study included all samples collected from 2018 to 2022. All samples were tested with Anyplex II STI7 (Seegene). Incidence rate (IR) was calculated, incidence rate ratios (IRRs) were assessed using Poisson regression model.
Results
The study included 13,504 samples belonging to 7,692 individuals. Overall positivity rate was 2.9% (95%CI 2.6–3.2). Subgroups showed significant differences: 13.6% in PrEP users, 5.2% in STI clinic, 4.6% in people living with HIV (PLWH), 1.2% in Gynecology/Obstetrics Department, 0.5% in Fertility clinic, and 0.5% in the “Other” group ( p < .001). A significant increasing temporal trend was registered for PLWH. Over a cumulative follow up of 2,554 years, 293 incident infections were registered with an IR of 11.5 per 100PYFU. Departments showed diverse IRs: 7.9 per 100PYFU for PLWH, 30.1 per 100PYFU for PrEP users, 22.7 per 100PYFU for STI clinic. Poisson regression model found a significant increase in incident rates over time in the overall study population driven by PLWH and PrEP users.
Conclusions
MG is uncommon in the general population with stable trends, while PLWH and PrEP users exhibit increasing positivity rate and incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- Clinical Microbiology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan, Milan, Italy.
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
- Chemical-Clinical Analysis Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
ORCID-Profile: Roberto Rossotti
Zitieren
APA
Rossotti, R., Nava, A., D'Amico, F., Baiguera, C., Fanti, D., Inglese, E., Raimondi, A., Bana, N. B., Spelzini, F., Bini, M., Vismara, C., & Puoti, M. (2025). Increasing incidence of Mycoplasma genitalium is driven by people living with HIV and PrEP users. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251315782
Vancouver
Rossotti R, Nava A, D'Amico F, Baiguera C, Fanti D, Inglese E, et al. Increasing incidence of Mycoplasma genitalium is driven by people living with HIV and PrEP users. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251315782
BibTeX
@article{Rossotti2025,
author = {Rossotti, Roberto and Nava, Alice and D'Amico, Federico and Baiguera, Chiara and Fanti, Diana and Inglese, Elvira and Raimondi, Alessandro and Bana, Nicholas Brian and Spelzini, Federico and Bini, Maurizio and Vismara, Chiara and Puoti, Massimo},
title = {Increasing incidence of Mycoplasma genitalium is driven by people living with HIV and PrEP users},
journal = {International Journal of STD & AIDS},
year = {2025},
doi = {10.1177/09564624251315782}
}
EUVIMED